Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Artiva Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 5 filings
- 1 insider, $5.08M in total
- Open-market sells
- 7 filings
- 4 insiders, $1.27M in total
- Insiders trading
- 5
- Net value
- +$3.81M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Artiva Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Aslan Fred | Chief Executive Officer | 1,604,765 | Sep 15, 2026 | 10 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 17,329,570Indirect | Sep 14, 2026 | 11 |
| Ra Capital Management, L.P. | Director, 10% Owner | 17,329,570Indirect | Sep 14, 2026 | 11 |
| Kolchinsky Peter | Director, 10% Owner | 17,329,570Indirect | Sep 14, 2026 | 11 |
| Shah Rajeev M. | Director, 10% Owner | 17,329,570Indirect | Sep 14, 2026 | 11 |
| RA Capital Nexus Fund, L.P. | Director | 17,329,570Indirect | Sep 14, 2026 | 11 |
| RA Capital Nexus Fund III, L.P. | Director | 17,329,570Indirect | Sep 14, 2026 | 11 |
| Stoppel Laura | Director | – | Sep 14, 2026 | 2 |
| Sorg Elaine K. | Director | – | Sep 14, 2026 | 3 |
| Hougen Elizabeth L | Director | – | Sep 14, 2026 | 2 |
| Daniels Brian | Director | – | Sep 14, 2026 | 2 |
| Baker Daniel G. | Director | – | Sep 14, 2026 | 2 |
| Moore Alison | Director | – | Sep 14, 2026 | 2 |
| Miralles Gines Diego | President & Head of R&D | 122,500 | Sep 11, 2026 | 2 |
| Horan Christopher | Chief Tech Operations Officer | 323,084 | Sep 11, 2026 | 6 |
| Bush Jennifer | COO, CLO, Compliance Officer | 374,529 | Sep 11, 2026 | 6 |
| Banerjee Subhashis | Chief Medical Officer | 170,947 | Sep 11, 2026 | 6 |
| GC Corp. | 10% Owner | 1,607,734Indirect | May 28, 2026 | 1 |
| GC Cell Corp | 10% Owner | 1,607,734Indirect | May 28, 2026 | 1 |
| Raymon Heather | SVP, Research and Development | 148,228 | May 19, 2026 | 4 |
| Huston Thad Allen | Chief Financial Officer | 220,000 | Mar 10, 2026 | 1 |
| Krishnamohan Neha | Chief Financial Officer | 99,356 | Nov 17, 2025 | 1 |
| Graef Thorsten | Chief Medical Officer | 80,000 | Feb 28, 2025 | 0 |
| Schwab Andrew J. | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| Parmar Kush | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| 5AM Ventures VI, L.P. | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| 5AM Partners VI, LLC | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| 5AM Opportunities II, L.P. | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| 5AM Opportunities II (GP), LLC | 10% Owner | 1,182,054Indirect | Jul 24, 2024 | 0 |
| Goodman Corey S | 10% Owner | 1,936,637 | Jul 22, 2024 | 0 |
| Adelman Robert J | 10% Owner | 1,936,637 | Jul 22, 2024 | 0 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 1,936,637 | Jul 22, 2024 | 0 |
| Venbio Global Strategic GP III, Ltd | 10% Owner | 1,936,637 | Jul 22, 2024 | 0 |
| Venbio Global Strategic GP III, L.P. | 10% Owner | 1,936,637 | Jul 22, 2024 | 0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 194,108 | Jul 22, 2024 | 0 |
| Huh Yong-Jun | Director | 1,260,512Indirect | Jul 22, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 (view filing) | Jul 22 | Same day | Huh Yong-JunDirector | PPurchase | +2.08M | $12.00 | +$25.0M | New position1.26M after | 2 lots |
| Jul 22, 2024 (view filing)8:25 PM ET | Jul 22 | Same day | GC Corp. and 1 other10% Owner | PPurchase | +1.67M | $12.00 | +$20.0M | +101.6%3.31M after | |
| Jul 22, 2024 (view filing)8:25 PM ET | Jul 22 | Same day | GC Corp. and 1 other10% Owner | PPurchase | +416.7K | $12.00 | +$5.00M | +49.4%1.26M after | |
| Jul 22, 2024 (view filing)8:26 PM ET | Jul 22 | Same day | Goodman Corey S and 4 others10% Owner | PPurchase | +416.7K | $12.00 | +$5.00M | +27.4%1.94M after | |
| Jul 24, 2024 (view filing)4:15 PM ET | Jul 22 | 2 days | Schwab Andrew J. and 5 others10% Owner | PPurchase | +833.3K | $12.00 | +$10.0M | +239.0%1.18M after | |
| Jul 24, 2024 (view filing)4:27 PM ET | Jul 22 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +8.33M | $12.00 | +$100.0M | New position826.8K after | 2 lots |
| Aug 18, 2025 (view filing) | Aug 15 | 3 days | Aslan FredPresident and CEO | SSale | −25.5K | $2.73 | −$69.6K | −6.2%386.7K after | 10b5-1 |
| Oct 17, 2025 (view filing) | Oct 17 | Same day | Aslan FredPresident and CEO | SSale | −25.5K | $6.00 | −$153.0K | −6.7%356.7K after | 10b5-1 |
| Nov 17, 2025 (view filing) | Nov 17 | Same day | Aslan FredPresident and CEO | SSale | −6.38K | $3.38 | −$21.5K | −1.8%344.0K after | 10b5-1 |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Aslan FredPresident and CEO | SSale | −3.19K | $6.00 | −$19.1K | −0.3%1.21M after | 10b5-1 |
| May 13, 2026 (view filing)5:45 PM ET | May 11 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +6.51M | $11.52 | +$75.0M | +74.9%15.2M after | |
| May 13, 2026 (view filing)5:45 PM ET | May 11 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +2.17M | $11.52 | +$25.0M | –2.17M after | Derivative |
| May 19, 2026 (view filing) | May 19 | Same day | Aslan FredChief Executive Officer | SSale | −27.1K | $9.01 | −$244.3K | −1.7%1.54M after | |
| May 19, 2026 (view filing) | May 19 | Same day | Banerjee SubhashisChief Medical Officer | SSale | −7.04K | $9.01 | −$63.4K | −4.6%145.0K after | |
| May 19, 2026 (view filing) | May 19 | Same day | Bush JenniferCOO, CLO, Compliance Officer | SSale | −8.79K | $9.01 | −$79.2K | −2.5%337.9K after | |
| May 19, 2026 (view filing) | May 19 | Same day | Horan ChristopherChief Tech Operations Officer | SSale | −7.00K | $9.01 | −$63.1K | −2.3%293.4K after | |
| May 19, 2026 (view filing) | May 19 | Same day | Raymon HeatherSVP, Research and Development | SSale | −3.10K | $9.01 | −$27.9K | −2.0%148.2K after | |
| May 28, 2026 (view filing)4:34 PM ET | May 11 | 17 daysLate | GC Corp. and 1 other10% Owner | PPurchase | +1.09M | $11.52 | +$12.5M | +32.8%4.39M after | |
| May 28, 2026 (view filing)4:34 PM ET | May 11 | 17 daysLate | GC Corp. and 1 other10% Owner | PPurchase | +347.2K | $11.52 | +$4.00M | +27.5%1.61M after | |
| Jun 11, 2026 (view filing)7:36 PM ET | Jun 9-11 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +1.03M | $7.44 | +$7.65M | +6.8%16.2M after | 3 lots |
| Jun 16, 2026 (view filing)6:08 PM ET | Jun 12-16 | 4 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +531.3K | $8.66 | +$4.60M | +3.3%16.8M after | 3 lots |
| Jun 29, 2026 (view filing)4:20 PM ET | Jun 25-26 | 4 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +32.9K | $8.89 | +$292.1K | +0.2%16.8M after | 2 lots |
| Jul 14, 2026 (view filing)7:00 PM ET | Jul 10 | 4 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +15.1K | $8.97 | +$135.5K | +0.1%16.8M after | From original |
| Jul 20, 2026 (view filing)6:08 PM ET | Jul 16-17 | 4 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +160.4K | $8.93 | +$1.43M | +1.0%17.0M after | 2 lots |
| Jul 23, 2026 (view filing)9:21 PM ET | Jul 13 | 10 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +6.52K | $8.94 | +$58.3K | 0.0%16.8M after | Amended |
| Jul 23, 2026 (view filing)9:22 PM ET | Jul 21-23 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +264.6K | $9.76 | +$2.58M | +1.6%17.2M after | 3 lots |
| Jul 28, 2026 (view filing)5:24 PM ET | Jul 24 | 4 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +41.3K | $9.99 | +$412.8K | +0.2%17.3M after | |
| Jul 31, 2026 (view filing)5:13 PM ET | Jul 29-31 | 2 days | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchase | +45.8K | $9.96 | +$455.7K | +0.3%17.3M after | 2 lots |
| Aug 19, 2026 (view filing)9:00 PM ET | Aug 18 | 1 day | Banerjee SubhashisChief Medical Officer | SSale | −429 | $12.00 | −$5.15K | −0.3%145.0K after | 10b5-1 |
| Aug 31, 2026 (view filing)7:06 PM ET | Aug 27 | 4 days | Banerjee SubhashisChief Medical Officer | SSale | −8.22K | $12.01 | −$98.7K | −5.5%142.0K after | 10b5-1 |
| Sep 4, 2026 (view filing)4:02 PM ET | Sep 3 | 1 day | Aslan FredChief Executive Officer | SSale | −61.9K | $11.16 | −$690.4K | −4.0%1.47M after | |
| Sep 4, 2026 (view filing)4:03 PM ET | Sep 3 | 1 day | Banerjee SubhashisChief Medical Officer | SSale | −1.10K | $11.16 | −$12.3K | −0.8%140.9K after | |
| Sep 4, 2026 (view filing)4:03 PM ET | Sep 3 | 1 day | Bush JenniferCOO, CLO, Compliance Officer | SSale | −8.39K | $11.16 | −$93.6K | −2.5%329.5K after | |
| Sep 4, 2026 (view filing)4:04 PM ET | Sep 3 | 1 day | Horan ChristopherChief Tech Operations Officer | SSale | −10.4K | $11.16 | −$115.6K | −3.5%283.1K after | |
| Sep 9, 2026 (view filing)4:02 PM ET | Sep 8 | 1 day | Aslan FredChief Executive Officer | SSale | −23.4K | $10.92 | −$255.7K | −1.6%1.45M after | 10b5-1 |